Parkinson

Neurology
3
Pipeline Programs
3
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Bial
BialPortugal - Coronado
3 programs
2
1
Opicapone 50 mgPhase 31 trial
BIA 9-1067Phase 11 trial
BIA 9-1067Phase 11 trial
Active Trials
NCT02305277CompletedEst. Jun 2014
NCT02071823CompletedEst. Jun 2008
NCT04978597CompletedEst. Jan 2024
BrainsWay
BrainsWayJerusalem, Israel
1 program
Brainsway Multiway deep TMS deviceN/A1 trial
Active Trials
Abbott
AbbottABBOTT PARK, IL
1 program
DBSN/A1 trial
Active Trials
NCT03630302Completed10Est. Jan 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BialOpicapone 50 mg
BialBIA 9-1067
BialBIA 9-1067
AbbottDBS
BrainsWayBrainsway Multiway deep TMS device

Clinical Trials (5)

Total enrollment: 10 patients across 5 trials

NCT04978597BialOpicapone 50 mg

Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)

Start: May 2021Est. completion: Jan 2024
Phase 3Completed
NCT02305277BialBIA 9-1067

Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers

Start: Mar 2014Est. completion: Jun 2014
Phase 1Completed
NCT02071823BialBIA 9-1067

Comparative Bioavailability Study of BIA 9-1067 25 mg Capsules

Start: May 2008Est. completion: Jun 2008
Phase 1Completed

Intraoperative Investigation of a Directional Lead and Local Field Potentials for the Optimization of Stimulation Efficacy

Start: Jul 2018Est. completion: Jan 202010 patients
N/ACompleted
NCT02249715BrainsWayBrainsway Multiway deep TMS device

Development of a Monitoring Set-up and Algorithm Using Functional MRI (fMRI) and EEG for Prediction of Response to Repetitive Deep Transcranial Magnetic Stimulation (rDTMS) for Patients With Parkinson's Disease

Start: Nov 2014
N/AUnknown

Related Jobs in Neurology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space